Long-Term Outcome Following Coronary Artery Stenting by History of Preterm Delivery

[1]  L. Zühlke,et al.  The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030 , 2021, The Lancet.

[2]  K. Rexrode,et al.  Adverse Pregnancy Outcomes and Cardiovascular Disease Risk: Unique Opportunities for Cardiovascular Disease Prevention in Women: A Scientific Statement From the American Heart Association. , 2021, Circulation.

[3]  A. Stroustrup,et al.  Pre-Term Delivery and Risk of Ischemic Heart Disease in Women. , 2020, Journal of the American College of Cardiology.

[4]  P. Serruys,et al.  Long-Term Outcomes in Women and Men Following Percutaneous Coronary Intervention. , 2020, Journal of the American College of Cardiology.

[5]  E. Rimm,et al.  Preterm Delivery and Maternal Cardiovascular Disease Risk Factors: The Nurses' Health Study II. , 2019, Journal of women's health.

[6]  G. Gore,et al.  Cardiovascular Disease-Related Morbidity and Mortality in Women With a History of Pregnancy Complications: Systematic Review and Meta-Analysis , 2019, Circulation.

[7]  S. Kilpatrick,et al.  Association of Spontaneous Preterm Delivery and Future Maternal Cardiovascular Disease , 2018, Circulation.

[8]  C. Chew‐Graham,et al.  Preterm Delivery and Future Risk of Maternal Cardiovascular Disease: A Systematic Review and Meta‐Analysis , 2018, Journal of the American Heart Association.

[9]  Paige L. Williams,et al.  Preterm Delivery and Maternal Cardiovascular Disease in Young and Middle-Aged Adult Women , 2017, Circulation.

[10]  W. Qiu,et al.  Gender Differences in Outcomes and Predictors of All-Cause Mortality After Percutaneous Coronary Intervention (Data from United Kingdom and Sweden). , 2017, The American journal of cardiology.

[11]  J. Harnek,et al.  Prognostic Impact of Chronic Total Occlusions: A Report From SCAAR (Swedish Coronary Angiography and Angioplasty Registry). , 2016, JACC. Cardiovascular interventions.

[12]  P. Serruys,et al.  Excess mortality in women compared to men after PCI in STEMI: an analysis of 11,931 patients during 2000-2009. , 2014, International journal of cardiology.

[13]  David Erlinge,et al.  Thrombus aspiration during ST-segment elevation myocardial infarction. , 2013, The New England journal of medicine.

[14]  Wei Liu,et al.  Long-term follow up of percutaneous coronary intervention of coronary artery disease in women ≤45 years of age. , 2013, The American journal of cardiology.

[15]  S. Cnattingius,et al.  Maternal Obesity and Risk of Preterm Delivery , 2014 .

[16]  Per Albertsson,et al.  Population trends in percutaneous coronary intervention: 20-year results from the SCAAR (Swedish Coronary Angiography and Angioplasty Registry). , 2013, Journal of the American College of Cardiology.

[17]  Samin K. Sharma,et al.  Female gender and mortality after percutaneous coronary intervention: Results from a large registry , 2012, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[18]  C. Reid,et al.  Long-term predictors of mortality after percutaneous coronary intervention in the era of drug-eluting stents. , 2011, The American journal of cardiology.

[19]  J. Lindbäck,et al.  Stent Thrombosis in Sweden: A Report From the Swedish Coronary Angiography and Angioplasty Registry , 2009, Circulation. Cardiovascular interventions.

[20]  J. Ludvigsson,et al.  The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research , 2009, European Journal of Epidemiology.

[21]  Ole Fröbert,et al.  Differences in restenosis rate with different drug-eluting stents in patients with and without diabetes mellitus: a report from the SCAAR (Swedish Angiography and Angioplasty Registry). , 2009, Journal of the American College of Cardiology.

[22]  B. Prendergast,et al.  Multivariate prediction of major adverse cardiac events after 9914 percutaneous coronary interventions in the north west of England , 2005, Heart.

[23]  B. Jacobsson,et al.  Preterm birth in Sweden 1973–2001: Rate, subgroups, and effect of changing patterns in multiple births, maternal age, and smoking , 2005, Acta obstetricia et gynecologica Scandinavica.

[24]  B. Davis,et al.  Outcomes in Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention in the Current Era: A Report From the Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) Trial , 2004, Circulation.

[25]  G. Booth,et al.  Prognosis after maternal placental events and revascularization: PAMPER study. , 2016, American journal of obstetrics and gynecology.

[26]  H. Gurm,et al.  The association of sex with outcomes among patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction in the contemporary era: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2). , 2011, American heart journal.